STEAP3是一种预后生物标志物,通过调节免疫微环境和PI3K-AKT通路来促进质瘤的进展
Zihan Song1,1, Zijun Zhao2,1, Siyu Zhu1
1Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Cancer biomarkers : section A of Disease markers
|November 19, 2023
概括
通过抑制免疫微环境和激活PI3K-AKT通路,STEAP3 (STEAP家族成员3) 促进质瘤的进展. 高STEAP3表达与较短的存活率相关,表明其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 金属还原酶STEAP3与瘤进展有关,但其预后价值和质瘤的机制尚不清楚.
- 了解STEAP3的作用对于开发球瘤向疗法至关重要.
研究的目的:
- 为了研究STEAP3在质瘤的预后意义.
- 阐明STEAP3参与质瘤进展的潜在机制,重点关注免疫微环境和信号通路.
主要方法:
- 在多个质瘤数据集中分析STEAP3表达和生存数据.
- 预后模型的构建 (ROC曲线,名图) 和考克斯回归分析.
- 免疫透,丰富分析和细胞实验,以探索STEAP3的功能影响和途径调节.
主要成果:
- STEAP3表达因质瘤等级,IDH和1p19q状态而异,高的STEAP3与患者存活率的降低相关,特别是在IDH突变天体细胞瘤中.
- STEAP3作为质瘤的独立预后因素,其预测价值通过ROC曲线和名图证实.
- 通过影响免疫抑制细胞透和癌症免疫循环,STEAP3促进了抑制免疫的微环境,并通过PI3K-AKT通路和M2巨细胞透驱动质瘤的进展.
结论:
- 通过调节免疫微环境和PI3K-AKT通路,STEAP3显著促进质瘤的进展.
- 在质瘤治疗中,STEAP3是一个有前途的治疗点.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K